{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:43:55Z","timestamp":1776843835997,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurgie de la Main"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.main.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T23:38:56Z","timestamp":1304206736000},"page":"239-245","source":"Crossref","is-referenced-by-count":8,"title":["Maladie de Dupuytren\u00a0: \u00e9tat des connaissances et de la recherche en physiopathologie"],"prefix":"10.1016","volume":"30","author":[{"given":"G.","family":"Carvalhana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Auquit-Auckbur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y.","family":"Milliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.main.2011.03.002_bib0005","series-title":"Chirurgie de la main","article-title":"Affections rhumatismales, d\u00e9g\u00e9n\u00e9ratives, syndromes canalaires","author":"Merle","year":"2007"},{"issue":"3","key":"10.1016\/j.main.2011.03.002_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1302\/0301-620X.91B3.21054","article-title":"Does a \u2018firebreak\u2019 full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?","volume":"91","author":"Ullah","year":"2009","journal-title":"J Bone Joint Surg Br"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0895-4356(01)00413-9","article-title":"Increased mortality and cancer mortality in men with Dupuytren's disease: a 15-year follow up study","volume":"55","author":"Gudmundsson","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.main.2011.03.002_bib0020","series-title":"Trait\u00e9 de chirurgie de la main","article-title":"Maladie de Dupuytren. Malformations cong\u00e9nitales. Amputations, proth\u00e8se, r\u00e9\u00e9ducation, la main dans l\u2019Art","author":"Tubiana","year":"1998"},{"issue":"4","key":"10.1016\/j.main.2011.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/01.prs.0000204585.97844.7e","article-title":"Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture","volume":"117","author":"Seyhan","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1297-3203(00)73455-X","article-title":"The effect of 5-florouracile on Dupuytren fibroblast proliferation and differentiation","volume":"19","author":"Jemec","year":"2000","journal-title":"Chir Main"},{"issue":"5","key":"10.1016\/j.main.2011.03.002_bib0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1054\/jhsb.1999.0251","article-title":"Is Dupuytren's disease caused by an imbalance between proliferation and cell death?","volume":"24","author":"Jemec","year":"1999","journal-title":"J Hand Surg Br"},{"issue":"2","key":"10.1016\/j.main.2011.03.002_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhsa.2005.09.007","article-title":"Expression of a novel gene, MafB, in Dupuytren's disease","volume":"31","author":"Lee","year":"2006","journal-title":"J Hand Surg Am"},{"issue":"10","key":"10.1016\/j.main.2011.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jhsa.2006.08.007","article-title":"Gelatinase A activity in Dupuytren's disease","volume":"31","author":"Augoff","year":"2006","journal-title":"J Hand Surg Am"},{"issue":"7","key":"10.1016\/j.main.2011.03.002_bib0050","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhsa.2008.04.002","article-title":"Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease","volume":"33","author":"Johnston","year":"2008","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.main.2011.03.002_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jhsa.2006.12.010","article-title":"A complete expression profile of Matrix-Degrading Metalloproteinases in Dupuytren's disease","volume":"32A","author":"Johnston","year":"2007","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-0712(21)00436-4","article-title":"Cellular structure and biology of Dupuytren's disease","volume":"15","author":"Tomasek","year":"1999","journal-title":"Hand Clin"},{"issue":"11","key":"10.1016\/j.main.2011.03.002_bib0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00402-008-0726-3","article-title":"Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease","volume":"129","author":"Ulrich","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"10.1016\/j.main.2011.03.002_bib0070","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.PRS.0000081462.40448.49","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease","volume":"112","author":"Ulrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.main.2011.03.002_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11552-009-9164-0","article-title":"Differential gene expression analysis of subcutaneous fat, fascia and skin overlying a Dupuytren's disease nodule in comparison to control tissue","volume":"4","author":"Shih","year":"2009","journal-title":"Hand"},{"key":"10.1016\/j.main.2011.03.002_bib0080","first-page":"5","article-title":"Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's disease","volume":"30","author":"O\u2019Gorman","year":"2006","journal-title":"J Negat Results Biomed"},{"key":"10.1016\/j.main.2011.03.002_bib0085","first-page":"4","article-title":"Elevated levels of beta-catenin and fibronectin in 3-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro","volume":"16","author":"Howard","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.main.2011.03.002_bib0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jss.2004.01.013","article-title":"Wound healing-associated proteins Hsp47\u00a0and fibronectin are elevated in Dupuytren's contracture","volume":"117","author":"Howard","year":"2004","journal-title":"J Surg Res"},{"issue":"2","key":"10.1016\/j.main.2011.03.002_bib0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","article-title":"The role of transforming growth factor beta in Dupuytren's disease","volume":"21","author":"Badalamente","year":"1996","journal-title":"J Hand Surg Am"},{"issue":"3","key":"10.1016\/j.main.2011.03.002_bib0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0363-5023(94)90059-0","article-title":"Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia","volume":"19","author":"Alioto","year":"1994","journal-title":"J Hand Surg Am"},{"issue":"6","key":"10.1016\/j.main.2011.03.002_bib0105","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhsa.2009.02.008","article-title":"Transforming growth factor beta 1\u00a0stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel","volume":"34","author":"Bisson","year":"2009","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-0712(21)00436-4","article-title":"Cellular structure and biology of Dupuytren's disease","volume":"15","author":"Tomasek","year":"1999","journal-title":"Hand Clin"},{"issue":"7","key":"10.1016\/j.main.2011.03.002_bib0115","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.PRS.0000060531.98180.32","article-title":"Genetic susceptibility to dupuytren disease: association of Zf9\u00a0transcription factor gene","volume":"111","author":"Bayat","year":"2003","journal-title":"Plast Recontr Surg"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1582-4934.2006.tb00297.x","article-title":"N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling","volume":"10","author":"Kopp","year":"2006","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2474-5-41","article-title":"Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2","volume":"5","author":"Tse","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.main.2011.03.002_bib0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/jsre.2001.6350","article-title":"Tamoxifen decreases fibroblast function and downregulates TGF-beta2\u00a0in Dupuytren's affected palmar fascia","volume":"103","author":"Kuhn","year":"2002","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.main.2011.03.002_bib0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.PRS.0000146038.61595.4A","article-title":"Epidermal growth factor in Dupuytren's disease","volume":"115","author":"Augoff","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.main.2011.03.002_bib0140","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhsb.2005.06.008","article-title":"Epidermal growth factor receptor in Dupuytren's disease","volume":"30","author":"Augoff","year":"2005","journal-title":"J Hand Surg Br"},{"issue":"4","key":"10.1016\/j.main.2011.03.002_bib0145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/path.2483","article-title":"An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease","volume":"217","author":"Kraljevic Pavelic","year":"2009","journal-title":"J Pathol"}],"container-title":["Chirurgie de la Main"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297320311000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297320311000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T14:51:48Z","timestamp":1686063108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297320311000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1297320311000485"],"URL":"https:\/\/doi.org\/10.1016\/j.main.2011.03.002","relation":{},"ISSN":["1297-3203"],"issn-type":[{"value":"1297-3203","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}